TAT 2012 - 10th International Congress on Targeted Anticancer Therapies

Inicio: 08/03/2012    Fin: 10/03/2012  
Web: www.esmo.org/events/targeted-anticancer-therapies-tat-2012/program.html  
Localidad: Amsterdam, Países Bajos
Especialidad: Oncología
Tipo evento: Congreso
Ámbito/Alcance: Internacional
Organizador: European Society for Medical Oncology (ESMO)
Ver en el mapa: Amsterdam

TAT 2012 in Amsterdam, The Netherlands, will be the tenth meeting in the series named in full "International Congress on Targeted Anticancer Therapies". Like all TAT meetings held since 2005, TAT 2012 will be another official ESMO Partnership Meeting. TAT 2012 is offered by the Amsterdam-based NDDO Education Foundation, and is co-sponsored by the U.S. National Cancer Institute - Center for Cancer Research.

TAT meetings are characterized by their focus on targeted cancer therapeutics, in particular the most promising ones in the late preclinical and early clinical development stages. TAT 2012 will offer excellent opportunities for the presentation and discussion of ongoing and completed phase 1 studies in a highly interactive setting. Apart from being of importance to everyone involved in anticancer drug development on a daily basis, the TAT 2012 program will also be of educational value to oncologists wishing to stay abreast of emerging new treatment options.

Distinguishing features of TAT 2012:

Highly focused on early phase development of promising targeted agents for cancer therapy
Medium-sized event, creating excellent possibilities for personal interactions with colleagues
Participants from academia and industry
No paralllel sessions, avoiding the need to make difficult choices
Attention to methodological and regulatory issues in new drug development
Ample opportunity to present your own work in front of an international expert audience
Amsterdam as the venue of TAT 2012 hardly needs any further introduction. By having TAT 2012 in Amsterdam, the congress returns to its city of origin, a city well known to many who attended previous NDDO new drug meetings. RAI Elicium, the congress venue, allows very convenient travel (e.g., only 10 minutes from Amsterdam Schiphol Airport by train).

GET A GLIMPSE OF THE FUTURE OF SYSTEMIC CANCER THERAPY AT TAT 2012
For further information, please visit: http://www.tatcongress.org/tat12-home.html

Important deadlines

Registration
January 8

Deadline early registration

January 15

Deadline registration presenting authors; necessary to ensure abstract scheduling

February 8

Deadline cancellation; reimbursement of registration fee, minus EUR 50.00 handling charges until this date

March 4

Deadline advance registration; no reduced fees as of March 5

March 8-10

On-site registration at venue open; registration hours to be announced


Abstracts
January 8

Deadline abstract submission

January 15

Deadline abstract withdrawal/modification

January 15

Deadline registration presenting authors; necessary to ensure abstract scheduling

January 25

Notification of abstract scheduling/rejection to submitting author

March 7

Date of release of submitted (accepted) and invited abstracts